Difference between revisions of "Paul Girolami"
m (add image) |
(unstub) |
||
| Line 1: | Line 1: | ||
{{person | {{person | ||
|wikipedia=https://en.wikipedia.org/wiki/Paul_Girolami | |wikipedia=https://en.wikipedia.org/wiki/Paul_Girolami | ||
| − | |description=Single Bilderberger Glaxo CEO | + | |description=Single Bilderberger [[Glaxo]] CEO |
|image=Glax paul.png | |image=Glax paul.png | ||
|alma_mater=London School of Economics | |alma_mater=London School of Economics | ||
| Line 9: | Line 9: | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
| + | |alma_mater=London School of Economics | ||
|constitutes=businessman | |constitutes=businessman | ||
| − | }}'''Sir Paul Girolami FREconS FIMC''' was chairman and chief executive of [[Big Pharma]] company [[Glaxo]]. | + | |employment={{job |
| + | |title=Chairman | ||
| + | |start=10 December 1985 | ||
| + | |end=November 1994 | ||
| + | |employer=Glaxo | ||
| + | |description=Company still called Glaxo | ||
| + | }}{{job | ||
| + | |title=CEO | ||
| + | |start= April 1980 | ||
| + | |end=1986 | ||
| + | |employer=Glaxo | ||
| + | |description=Company still called Glaxo | ||
| + | }} | ||
| + | }}'''Sir Paul Girolami FREconS FIMC''' was chairman and chief executive of [[Big Pharma]] company [[Glaxo]]; he made Glaxo into a worldwide success. | ||
| + | |||
| + | ==Early life== | ||
| + | He was born in Italy. He attended the [[London School of Economics]]. | ||
| + | |||
| + | ==Career== | ||
| + | ===Glaxo=== | ||
| + | He joined Glaxo in 1965 as a Financial Controller. He became finance director in 1968 when aged 42. In April 1980 it was announced that he would become chief executive. In the early 1980s, Glaxo briefly surpassed [[BT Group|British Telecom]] to become Britain's most valued company on the stock market ([[London Stock Exchange|LSE]]), and Glaxo was the world's second-largest pharmaceutical company and remained so into the 1990s; it had been 25th largest in the world in 1980. The reasons for this were a huge increase in its R&D budget, and employing many more researchers; by 1993 it was spending $750 million on research with around 5,500 researchers, of which 3,500 were in the UK. Its other researchers were in Italy, the US and Japan. In April 1985 he was appointed as deputy chairman, and it was announced that he would be leaving his post as chief executive in early 1986. On 10 December 1985 he became chairman of Glaxo. He left as chairman in November 1994, when aged 68.<ref>[https://www.independent.co.uk/news/business/girolami-to-retire-as-chairman-of-glaxo-decision-to-step-down-early-leaves-power-over-group-firmly-1422978.html ''Independent'' 1994]</ref> | ||
| + | |||
| + | Glaxo merged to become Glaxo Wellcome a year later in 1995. Glaxo drugs that sold well included the Fortum ([[ceftazidime]]) and Zinnat ([[cefuroxime axetil]]) antibiotics. | ||
| + | |||
| + | ==Personal life== | ||
| + | He married in 1952; his wife died in 2009. They had two sons and a daughter. He was knighted in the [[1988 New Year Honours]], when chairman of Glaxo Holdings. | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
Latest revision as of 02:59, 13 July 2022
 Paul Girolami    (businessman) | |
|---|---|
 | |
| Born | 25 January 1926 |
| Nationality | UK, Italy |
| Alma mater | London School of Economics |
Sir Paul Girolami FREconS FIMC was chairman and chief executive of Big Pharma company Glaxo; he made Glaxo into a worldwide success.
Early life
He was born in Italy. He attended the London School of Economics.
Career
Glaxo
He joined Glaxo in 1965 as a Financial Controller. He became finance director in 1968 when aged 42. In April 1980 it was announced that he would become chief executive. In the early 1980s, Glaxo briefly surpassed British Telecom to become Britain's most valued company on the stock market (LSE), and Glaxo was the world's second-largest pharmaceutical company and remained so into the 1990s; it had been 25th largest in the world in 1980. The reasons for this were a huge increase in its R&D budget, and employing many more researchers; by 1993 it was spending $750 million on research with around 5,500 researchers, of which 3,500 were in the UK. Its other researchers were in Italy, the US and Japan. In April 1985 he was appointed as deputy chairman, and it was announced that he would be leaving his post as chief executive in early 1986. On 10 December 1985 he became chairman of Glaxo. He left as chairman in November 1994, when aged 68.[1]
Glaxo merged to become Glaxo Wellcome a year later in 1995. Glaxo drugs that sold well included the Fortum (ceftazidime) and Zinnat (cefuroxime axetil) antibiotics.
Personal life
He married in 1952; his wife died in 2009. They had two sons and a daughter. He was knighted in the 1988 New Year Honours, when chairman of Glaxo Holdings.
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Bilderberg/1987 | 24 April 1987 | 26 April 1987 | Italy Cernobbio | 35th Bilderberg, in Italy, 106 participants |
